BioStock Analytics - Biostock

CONSENSUS ANALYSIS

Consensus Analysis | SOBI | 13 August 2026

Consensus Analysis | Getinge | 11 August 2026

Consensus Analysis | Astra Zeneca | 6 August 2026

WEEKLY: The Nordic Pulse

Novo raises outlook, BioInvent breaks through, Nordics tread water – the Nordic Pulse | 2026:32

Novo misses, AstraZeneca holds steady, Alvotech clears FDA – the Nordic Pulse | 2026:31

Novo sues Lilly, Alligator collapses, Lundbeck completes Phase III – the Nordic Pulse | 2026:30

BioStock Analytics

We deliver accessible sector news, in-depth company insights alongside trusted data and industry-wide market intelligence.

BioVal – rNPV analyses

BioVal™ analysis: Alzinova’ ALZ-101 valued at SEK 7.1B

BioVal™ analysis: Elicera Therapeutics’ ELC-301 valued at SEK 631M

QUARTERLY: The State of Nordic Biopharma

State of Nordic Biopharma | Q2 2026

State of Nordic Biopharma | Q1 2026

WEEKLY: The Nordic Pulse (cont.)

Leqembi under the skin, Wegovy wins Europe, Sobi lifts guidance – the Nordic Pulse | 2026:29

AstraZeneca drags the index, Ascelia contests the FDA and board drama at BICO – the Nordic Pulse | 2026:28

Hansa closes, AlzeCure soars, Ascelia falters – the Nordic Pulse | 2026:27

BioArctic lands Lilly, Sobi takes a late hit – the Nordic Pulse | 2026:26

Alvotech cashes up, SynAct narrowly misses – the Nordic Pulse | 2026:25

Lilly calls on AlzeCure, Novo Nordisk pops a pill – the Nordic Pulse | 2026:24

Lundbeck breaks through, Sectra breaks records – The Nordic Pulse | 2026:23

Hansa shines, Elekta stumbles, biotech bounces – the Nordic Pulse | 2026:22

Deals, Data and a Dragon Market Debut – the Nordic Pulse | 2026:21

Contracts, Catalysts and Caution – the Nordic Pulse | 2026:20

Weight, Winners and Watchpoints – the Nordic Pulse | 2026:19

The Nordic Pulse | 2026:18